Vaccination against SARS-CoV-2 reduces the risk of developing long covid symptoms
IDIAPJGol participates in a cohort study published in The Lancet Respiratory Medicine that collects data from more than twenty million people from Catalonia, the United Kingdom and Estonia. The work shows that vaccines against covid-19 are up to 52 % effective in preventing post-covid syndrome
Author: Ariadna Creus i Àngel García, Banc d'imatges infermeres